{
  "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
  "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 120,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Uses a horizontal progression layout to represent strategic evolution.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/12",
  "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
  "deckJsonHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817.json",
  "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.96,
        "x": 0.02,
        "y": 0.025
      },
      "kind": "diagram",
      "text": "Three-stage progression from 'Driving transformation today' to 'Mid-term goals' to 'Long-term vision'",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5e675f7-c72c-459e-a63b-7ea9d2662928",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.78,
        "y": 0.042
      },
      "kind": "list",
      "text": "Maintain and deepen COVID-19 vaccine leadership; Approved products across various disease areas",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1888af10-5861-40a4-be2b-637ff02e7fe9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.04,
        "y": 0.042
      },
      "kind": "list",
      "text": "1 marketed vaccine; Market leader in COVID-19 vaccines; 16 programs in 21 clinical trials; 5 randomized Phase 2 trials; 1 Phase 1 program; 10+ preclinical programs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28d5e2ac-2777-4b33-8bed-00ed20dd6f6a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.45,
        "y": 0.042
      },
      "kind": "list",
      "text": "Next-gen or variant adapted COVID-19 vaccines; Multiple product launches in next 3-5 years; 5-10 IND submissions per year",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c1b0e08-db12-4ddd-af32-f53329047187",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.083
      },
      "kind": "paragraph",
      "text": "By 2030, we aim to be a multi-product global biotechnology leader, aspiring to address the world's most pressing health challenges with pioneering, disruptive technologies delivered at scale",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc0ce538-25b6-400e-ba52-f1c93fed2d2b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Advancing toward our long-term vision",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "661a954d-2d2a-45a9-8084-91801898a17f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "46345616-acf7-4b41-b77d-212917f47ded",
      "evidence": "The slide uses a three-stage horizontal progression to map current, mid-term, and long-term strategic goals.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 10,
      "beatId": "97149298-ce68-4bbe-9759-62673752d664",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution Overview",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The presentation then provides an overview of BioNTech's solution, including its innovation pillars and mRNA technology",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 7,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "ac68e7db-aea6-4d80-8edc-ba3ff205e332",
      "evidence": "The presentation opens with a clear problem statement and builds a logic chain to introduce BioNTech's solution",
      "position": 0,
      "objective": "Explain the role of the immune system in human diseases and BioNTech's solution",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 30,
      "from": 10,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "5abee4e9-bad9-4c98-8e0f-028711be24f9",
      "evidence": "The presentation uses the Golden Circle framework to explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
      "position": 1,
      "objective": "Explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}